<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02706769</url>
  </required_header>
  <id_info>
    <org_study_id>AC15006</org_study_id>
    <nct_id>NCT02706769</nct_id>
  </id_info>
  <brief_title>Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Pain</brief_title>
  <acronym>PaSO</acronym>
  <official_title>A Double-blind Randomised Parallel Group Trial of Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Related Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Lothian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      National guidelines advocate the use of paracetamol in conjunction with strong opioids for
      cancer pain, despite a lack of evidence for its efficacy. Work is needed to examine the
      analgesic benefit of paracetamol in this large patient group. The investigators aim to
      establish if paracetamol in combination with strong opioids provides superior analgesia for
      cancer related pain over strong opioids alone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants with a 30% increase in total Brief Pain Inventory between day 0 and day 14 in the active drug group versus the placebo group.</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will take blinded Paracetamol (as they were taking before entering the study)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will take blinded Paracetamol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Study medication contains blinded placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>Study medication contains blinded paracetamol</description>
    <arm_group_label>Paracetamol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 16 years and over

          2. Under palliative care/oncology service review

          3. Diagnosis of incurable cancer

          4. Clinician-predicted life expectancy &gt;2 months

          5. Anticipated to be clinically stable for duration of study involvement

          6. Receiving daily regular strong opioids

          7. Able to take study drug/placebo in its current form

          8. Prescribed and taking paracetamol 1g four times a day

          9. Average pain &gt;3 and &lt;9 in past 24 hours

         10. Able to provide written informed consent

         11. Able to complete necessary assessments required as part of the trial

         12. Average NRS pain score stable (ie. maximum range of 1 point) for the three consecutive
             days prior to randomisation

        Exclusion Criteria:

          1. Pain which the clinician deems to be unstable

          2. Clinically significant renal or liver disease

          3. Weight less than 50kg

          4. Those whose pain is expected to change during the course of the study as a result of
             oncological or other treatments

          5. Co-enrolment in other drug trials

          6. Known to be pregnant or breast-feeding at the time of recruitment

          7. Previously enrolled in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lucy Norris</last_name>
    <phone>0131 651 8601</phone>
    <email>lucy.norris@ed.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Fallon</last_name>
    <phone>0131 651 8600</phone>
    <email>marie.fallon@ed.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH4 2XR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Fallon</last_name>
      <phone>0131 651 8611</phone>
      <email>marie.fallon@ed.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Lucy Norris</last_name>
      <phone>0131 651 8601</phone>
      <email>lucy.norris@ed.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2016</study_first_submitted>
  <study_first_submitted_qc>March 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2016</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

